Atossa Therapeutics
ATOS
#9429
Rank
NZ$0.14 B
Marketcap
NZ$1.12
Share price
-1.21%
Change (1 day)
-32.10%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: NZ$0.14 Billion

As of January 2026 Atossa Therapeutics has a market cap of NZ$0.14 Billion. This makes Atossa Therapeutics the world's 9429th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.14 B-1.33%
2025NZ$0.14 B-32.85%
2024NZ$0.21 B25.51%
2023NZ$0.17 B65.42%
2022NZ$0.10 B-64.46%
2021NZ$0.29 B373.79%
2020NZ$62.6 M194.11%
2019NZ$21.28 M139.42%
2018NZ$8.89 M-24.56%
2017NZ$11.78 M52.84%
2016NZ$7.71 M-49.5%
2015NZ$15.26 M-65.94%
2014NZ$44.83 M-14.51%
2013NZ$52.43 M-14.38%
2012NZ$61.24 M

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Atossa Therapeutics was reported to be:

NZ$0.14 Billion
by Nasdaq info icon info icon
NZ$0.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$856.93 B 590,857.36%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$36.41 B 25,011.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$33.94 B 23,309.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$63.67 M-56.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$4.91 B 3,288.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$2.96 B 1,943.41%๐Ÿ‡บ๐Ÿ‡ธ USA